We operate from state-of-the-art manufacturing and clinical facilities in the U.S. and U.K. Learn about our capabilities.
Our facilities include two clinical pharmacology units, two purpose-built pharmaceutical development and manufacturing sites. We support you by working under FDA or MHRA guidelines and offer a full range of support services, from study setup through to data analysis and reporting.
Global formulation and manufacturing
Pharmaceutical development and manufacturing facilities in the U.S. and U.K.
Production of Phase I – Phase III clinical drug supplies
Commercial product manufacture for solid dosage forms and liquid formats
U.S. facility is FDA / EMA / PMDA approved, U.K. facility is MHRA approved
GMP manufacturing suites globally including high potent compound handling
Scalable manufacturing equipment for non-sterile dosage forms
Batch sizes ranging from small scale (200g) to large scale (500kg) for tablet and capsule drug products and up to 350L for liquid presentations
Clinical packaging, labeling and global distribution for Phase I – Phase IIb programs
Global clinical pharmacology
Two purpose built Phase I units in the U.S. (Miami) and U.K. (Nottingham)
>245 bed capacity across Miami (U.S.), and Nottingham (U.K.)
Experienced team of 16 physicians and principal investigators
>1,300 Phase I studies completed to date
Database of >25,000 active participants across a broad demographic
Medical writing, data management, pharmacokinetics, statistical analysis and reporting